Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Reviews in Endocrine & Metabolic Disorders|June 8, 2025
Pregnancy-associated thyroid disorders: the role of genetic, epigenetic, and oxidative stress factorsAngelika Buczyńska, Iwona Sidorkiewicz, Justyna Hryniewicka, et al.BMC Cancer|May 1, 2019
Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancersIwona Sidorkiewicz, Monika Zbucka-Krętowska, Kamil Zaręba, et al.Journal of Perinatal Medicine|July 27, 2019
Simultaneous analysis of bisphenol A fractions in maternal and fetal compartments in early second trimester of pregnancyMonika Zbucka-Krętowska, Urszula Łazarek, Wojciech Miltyk, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2018
Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patientsMonika Zajkowska, Monika Zbucka-Krętowska, Iwona Sidorkiewicz, et al.Folia Histochemica Et Cytobiologica|November 1, 2011
Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapseMonika Zbucka-Kretowska, Naama Marcus-Braun, Cyril Eboue, et al.Cancer Control : Journal of the Moffitt Cancer Center|July 25, 2018
Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC AnalysisMonika Zajkowska, Monika Zbucka-Krętowska, Iwona Sidorkiewicz, et al.Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 15, 2017
[The plasma levels and diagnostic utility of matrix metalloproteinase-9 and CA 125 in cervical cancer patients]Emilia Lubowicka, Ewa Gacuta, Monika Zajkowska, et al.Frontiers in Endocrinology|March 28, 2022
miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes MellitusIlona Juchnicka, Mariusz Kuźmicki, Magdalena Niemira, et al.Pathology Oncology Research : POR|March 2, 2019
Diagnostic Power of Cytokine M-CSF, Metalloproteinase 2 (MMP-2) and Tissue Inhibitor-2 (TIMP-2) in Cervical Cancer Patients Based on ROC AnalysisEmilia Lubowicka, Monika Zbucka-Kretowska, Iwona Sidorkiewicz, et al.Nutrients|December 17, 2024
The Relationship Between Body Composition Parameters and the Intake of Selected Nutrients, and Serum Anti-Müllerian Hormone (AMH) Levels in the Context of Ovulatory InfertilityMagdalena Skowrońska, Michał Pawłowski, Angelika Buczyńska, et al.Pageof 6